Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T
Abstract
The first clinical results of using superparamagnetic ferrite particles as a tissue-specific contrast agent for MR of the liver are reported at high fields (1.5 T). Fifteen patients with proved secondary liver malignancies were studied with plain and contrast-enhanced MR. Superparamagnetic iron oxide was administrated IV in a dose of 20 mumol/kg. Intermediate TR, 820/30, 60 (TR/TE), and long TR, 2200/22, 70, spin-echo sequences were used before and 1 hr after injection of contrast material. Before injection, the largest number of lesions (437) was detected with the T2-weighted sequence. Lesion-to-liver contrast, expressed as the difference between the tumor and liver signal-to-noise, improved after ferrite administration in both sequences from -1 to 20 and from 7 to 15 for the 820/30, 60 sequence and from 9 to 34 and 15 to 21 for the 2200/22, 70 sequence. Despite this significant improvement in terms of the number of lesions detected, contrast-enhanced images did not show significantly more metastases than the unenhanced T2-weighted images did (383, 421, 407, and 407 vs as many as 437, respectively). In this limited study at 1.5 T, the benefit of ferrite enhancement was only marginal when postcontrast images were compared with heavily T2-weighted precontrast scans.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Due to high liver uptake, iron oxide nanoparticles have been employed relatively extensively for visualizing primary lesions in the liver, such as hepatocellular carcinoma and liver metastases.
“Due to their high liver uptake, iron oxide nanoparticles have been employed relatively extensively for visualizing primary lesions in the liver, e.g. in case of hepatocellular carcinoma (HCC) (Figure 3 A, B) as well as liver metastases (Figure 3 C, D) [144, 145].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [144]
Cited by
Sorted by citations
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181 · see citing works
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles
Raynal, I., Prigent, P., Peyramaure, S., Najid, A., Rebuzzi, C., & Corot, C. (2003) · Investigative Radiology · doi:10.1097/01.rli.0000101027.57021.28 · Cited by 402 · see citing works
Petri‐Fink, A., Chastellain, M., Juillerat‐Jeanneret, L., Ferrari, A., & Hofmann, H. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.023 · Cited by 343 · see citing works
Effects of Magnetic Fluid Hyperthermia (MFH) on C3H mammary carcinomain vivo
Jordan, A., Scholz, R., Wust, P., Fähling, H., Krause, J., Wlodarczyk, W., Sander, B., Vogl, T., & FELIX, R. (1997) · International Journal of Hyperthermia · doi:10.3109/02656739709023559 · Cited by 325 · see citing works
Burlec, A. F., Corciovă, A., Boev, M., Batir, D. M., Mircea, C., Cioancă, O., Danila, G., Dănilă, D. M., Bucur, A. F., & Hăncianu, M. (2023) · Pharmaceuticals · doi:10.3390/ph16101410 · Cited by 318 · see citing works
Rana, S., Gallo, A. A., Srivastava, R. S., et al. (2007) · Acta Biomaterialia · doi:10.1016/j.actbio.2006.10.006 · Cited by 294 · see citing works
Poly( l -lysine)-Modified Iron Oxide Nanoparticles for Stem Cell Labeling
Babič, M., Horák, D., Trchová, M., Jendelová, P., Glogarová, K., Lesný, P., Herynek, V., Hájek, M., & Syková, E. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700410z · Cited by 291 · see citing works
Ward, J., Naik, K. S., Guthrie, J. A., Wilson, D. J., & Robinson, P. J. (1999) · Radiology · doi:10.1148/radiology.210.2.r99fe05459 · Cited by 228 · see citing works
Hilger, I., Andrä, W., Hergt, R., et al. (2001) · Radiology · doi:10.1148/radiology.218.2.r01fe19570 · Cited by 224 · see citing works
Detection of magnetic nanoparticles in tissue using magneto-motive ultrasound
Oh, J., Feldman, M. D., Kim, J., Condit, C., Emelianov, S., & Milner, T. E. (2006) · Nanotechnology · doi:10.1088/0957-4484/17/16/031 · Cited by 212 · see citing works
Phase I clinical evaluation of a new iron oxide MR contrast agent
McLachlan, S. J., Morris, M. R., Lucas, M. A., Fisco, R. A., Eakins, M. N., Fowler, D. R., Scheetz, R. B., & Olukotun, A. Y. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040313 · Cited by 194 · see citing works
Hamm, B., Staks, T., Taupitz, M., Maibauer, R., Speidel, A., Huppertz, A., Frenzel, T., Lawaczeck, R., Wolf, K. J., & Lange, L. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040508 · Cited by 187 · see citing works
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
Reimer, P., & Tombach, B. (1998) · European Radiology · doi:10.1007/s003300050535 · Cited by 188 · see citing works
Bjørnerud, A., & Johansson, L. O. M. (2004) · NMR in Biomedicine · doi:10.1002/nbm.904 · Cited by 174 · see citing works
Heating Potential of Iron Oxides for Therapeutic Purposes in Interventional Radiology
Hilger, I., Frühauf, K., Andrä, W., Hiergeist, R., Hergt, R., & Kaiser, W. A. (2002) · Academic Radiology · doi:10.1016/s1076-6332(03)80171-x · Cited by 160 · see citing works
Biodistribution and toxicity of MR imaging contrast media
Øksendal, A. N., & Hals, P. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030128 · Cited by 156 · see citing works
Tang, Y., Yamashita, Y., Arakawa, A., et al. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.172.6.10350287 · Cited by 151 · see citing works
Das, M., Mishra, D., Maiti, T. K., et al. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/41/415101 · Cited by 131 · see citing works
Bartolozzi, C., Donati, F., Cioni, D., et al. (2004) · European Radiology · doi:10.1007/s00330-003-1966-9 · Cited by 116 · see citing works
“hanced MRI for increasing tumor-to-liver contrast and improving lesion conspicuity on T2-weighted images [27, 28, 29].”
BackgroundSchultz, J. F., Bell, J. D., Goldstein, R. M., et al. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0691-2 · Cited by 116 · see citing works
Chertok, B., Cole, A. J., David, A. E., & Yang, V. C.-M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900161h · Cited by 103 · see citing works
Wood, M. L., & Hardy, P. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030127 · Cited by 102 · see citing works
Magnetic Resonance Imaging of Focal Liver Lesions
Vogl, T. J., Hammerstingl, R., Schwarz, W., Kümmel, S., Müller, P., Balzer, T., Lauten, M., Balzer, J. O., Mack, M. G., Schimpfky, C., et al. (1996) · Investigative Radiology · doi:10.1097/00004424-199611000-00004 · Cited by 98 · see citing works
Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review
Butler, C., Thompson, R. B., Haykowsky, M. J., et al. (2009) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-11-7 · Cited by 93 · see citing works
Superparamagnetic Silica‐Iron Oxide Nanocomposites for Application in Hyperthermia
Chastellain, M., Petri, A., Gupta, A., Rao, K. V., & Hofmann, H. (2004) · Advanced Engineering Materials · doi:10.1002/adem.200300574 · Cited by 86 · see citing works
Laparoscopic Ultrasound vs Triphasic Computed Tomography for Detecting Liver Tumors
Foroutani, A. (2000) · Archives of Surgery · doi:10.1001/archsurg.135.8.933 · Cited by 88 · see citing works
Frate, C. D., Bazzocchi, M., Mortelé, K. J., et al. (2002) · Radiology · doi:10.1148/radiol.2253011854 · Cited by 80 · see citing works
Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results
Rr, E., Siegel, J., Singer, A., et al. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.153.6.1213 · Cited by 77 · see citing works
Magnetite nanoparticles prepared by the glass crystallization method and their physical properties
Woltz, S., Hiergeist, R., Görnert, P., et al. (2005) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2005.02.067 · Cited by 75 · see citing works
Canet‐Soulas, E., Revel, D., Forrat, R., Baldy, C., de Lorgeril, M., Sebbag, L., Vallée, J., Didier, D., & AMIEL, M. (1993) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(93)90241-5 · Cited by 70 · see citing works
LIVER-SPECIFIC MR IMAGING CONTRAST AGENTS
Hahn, P. F., & Saini, S. (1998) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70022-1 · Cited by 74 · see citing works
Fat-saturation MR imaging of the upper abdomen.
Semelka, R. C., Chew, W., Hricak, H., et al. (1990) · American Journal of Roentgenology · doi:10.2214/ajr.155.5.2120945 · Cited by 71 · see citing works
Ward, J., Chen, F., Guthrie, J. A., Wilson, D. J., Lodge, J. P. A., Wyatt, J. I., & Robinson, P. J. (2000) · Radiology · doi:10.1148/radiology.214.1.r00ja21159 · Cited by 68 · see citing works
Poeckler-Schoeniger, C., Koepke, J., Gueckel, F., et al. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00180-5 · Cited by 60 · see citing works
MR IMAGING TECHNIQUES OF THE LIVER
Siegelman, E. S., & Outwater, E. K. (1998) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70021-x · Cited by 58 · see citing works
Meledandri, C. J., Stolarczyk, J. K., Ghosh, S., et al. (2008) · Langmuir · doi:10.1021/la8018088 · Cited by 58 · see citing works
Biomedical applications of multifunctional magnetoelectric nanoparticles
Apu, E. H., Nafiujjaman, M., Sandeep, S., Makela, A. V., Khaleghi, A., Vainio, S. J., Contag, C. H., Li, J., Balasingham, I., Kim, T., et al. (2022) · Materials Chemistry Frontiers · doi:10.1039/d2qm00093h · Cited by 56 · see citing works
Magnetic Fluid Hyperthermia (MFH)
Jordan, A., Wust, P., Scholz, R., et al. (1997) · Springer eBooks · doi:10.1007/978-1-4757-6482-6_43 · Cited by 55 · see citing works
Namkung, S., Zech, C. J., Helmberger, T. K., Reiser, M. F., & Schoenberg, S. O. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20873 · Cited by 54 · see citing works
Semelka, R. C., Shoenut, J. P., Ascher, S. M., et al. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040316 · Cited by 54 · see citing works
Iron oxides as MR imaging contrast agents
Fahlvik, A. K., Klaveness, J., & Stark, D. D. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030131 · Cited by 53 · see citing works
Comparison of Gd‐EOB‐DTPA and Gd‐DTPA for contrast‐enhanced MR imaging of liver tumors
Clémеnt, O., Mühler, A., Vexler, V. S., et al. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030113 · Cited by 50 · see citing works
Lencioni, R. A., Donati, F., Cioni, D., et al. (1998) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/bf02592232 · Cited by 49 · see citing works
Contrast agents for MR imaging of the liver
Low, R. N. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070109 · Cited by 48 · see citing works
Nakamura, H., Ito, N., Kotake, F., et al. (2000) · Journal of Gastroenterology · doi:10.1007/s005350070022 · Cited by 47 · see citing works
“(1) Tumor detection rate by each examination method (dynamic CT, plain MRI, Gd dynamic MRI, and SPIO-MRI) (2) Diagnostic accuracy (3) Comparison among rates of detection of tumors with varying nodular diameters (4) Intratumor blood flow patterns and detection rates (5) Detection rate for each SPIO-MRI sequence (6) His…”
MethodHepatic metastases: CT versus MR imaging at 1.5T
Vassiliades, V. G., Foley, W. D., Alarcon, J., et al. (1991) · Abdominal Imaging · doi:10.1007/bf01887334 · Cited by 46 · see citing works
“5T and ferrite-enhanced MR in the detection of focal hepatic lesions [9].”
BackgroundSchwartz, L. H., Seltzer, S. E., Tempany, C. M., et al. (1995) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880050516 · Cited by 44 · see citing works
Biophysical properties and clinical applications of magnetic resonance imaging contrast agents
Vré, R. M.-D., & Lemort, M. (1995) · British Journal of Radiology · doi:10.1259/0007-1285-68-807-225 · Cited by 43 · see citing works
LIVER II: IRON OXIDE-BASED RETICULOENDOTHELIAL CONTRAST AGENTS FOR MR IMAGING
Petersein, J., Saini, S., & Weissleder, R. (1996) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/s1064-9689(21)00553-5 · Cited by 43 · see citing works
Woltz, S., & Rüssel, C. (2004) · Journal of Non-Crystalline Solids · doi:10.1016/j.jnoncrysol.2004.04.015 · Cited by 42 · see citing works
Spio-MR Imaging versus Double-Phase Spiral CT in Detecting Malignant Lesions of the Liver
Müller, R.-D., Vogel, K., Neumann, K., et al. (1999) · Acta Radiologica · doi:10.3109/02841859909175600 · Cited by 41 · see citing works
Fujita, M., Yamamoto, R., Fritz‐Zieroth, B., Yamanaka, T., Takahashi, M., Miyazawa, T., Tatsuta, M., Terada, N., Hosomi, N., Inoue, E., et al. (1996) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880060310 · Cited by 39 · see citing works
Superparamagnetic iron oxide: Detection of focal liver lesions at high‐field‐strength MR imaging
Duda, S. H., Laniado, M., Kopp, A. F., et al. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040314 · Cited by 40 · see citing works
Dextran magnetite as a liver contrast agent
Magin, R. L., Bacic, G., Niesman, M. R., et al. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910200102 · Cited by 39 · see citing works
Mergo, P. J., Engelken, J. D., Helmberger, T. K., et al. (1998) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880080511 · Cited by 38 · see citing works
Yang, J. H., Ramaraj, B., & Yoon, K. R. (2013) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2013.08.152 · Cited by 37 · see citing works
Schultz, J. F., Bell, J. D., Goldstein, R. M., et al. (1999) · Annals of Surgical Oncology · doi:10.1007/pl00021736 · Cited by 37 · see citing works
Rummeny, E., & Marchal, G. (1997) · Acta Radiologica · doi:10.1080/02841859709172392 · Cited by 35 · see citing works
Self-citationTamhankar, P. M., Kulkarni, A. M., & Watawe, S. C. (2011) · Materials Sciences and Applications · doi:10.4236/msa.2011.29179 · Cited by 33 · see citing works
“The soft magnetic materials have potential applications as carriers for targeted drug delivery but there are limitations due to their toxicity [1-8].”
BackgroundMechanistic Understanding of Toxicity from Nanocatalysts
Jiang, C., Jia, J., & Zhai, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813967 · Cited by 33 · see citing works
“Based on animal studies and human trials, high amounts of SPIONPs may be toxic, whereas a low concentration of NPs appears to be biocompatible [192–194].”
BackgroundKolosnjaj‐Tabi, J., Kralj, S., Griseti, E., Nemec, S., Wilhelm, C., Sangnier, A. P., Bellard, E., Fourquaux, I., Golzio, M., & Rols, M. (2019) · Cancers · doi:10.3390/cancers11122040 · Cited by 32 · see citing works
“Iron oxide nanoparticles were historically used as contrast agents for magnetic resonance imaging (MRI), mostly to detect liver metastases [2].”
BackgroundAlbukhaty, S., Naderi‐Manesh, H., & Tiraihi, T. (1996) · PubMed · doi:10.6091/ibj.1114.2013 · Cited by 31 · see citing works
“Due to their low toxicity in animal tissues [9], their applications also include the detection of oligonucleotides, DNA, proteins, and immunoassays [9-12].”
BackgroundKaygısız, Ş. Y., & Çiğerci, İ. H. (2017) · Toxicology and Industrial Health · doi:10.1177/0748233717722907 · Cited by 31 · see citing works
“Nowadays, iron oxide (Fe2O3) nanoparticles (IONPs) are extensively being used for several purposes, like radiological diagnostic procedures, detoxification of biologic fluids, immunoassay, and drug delivery, for example (Bellin et al., 2000; Marchal et al., 1989; Nanz et al., 2000; Saini et al., 2000).”
BackgroundNEW MR IMAGING CONTRAST AGENTS
Earls, J. P., & Bluemke, D. A. (1999) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/s1064-9689(21)00021-0 · Cited by 30 · see citing works
Smart RISUG: A potential new contraceptive and its magnetic field-mediated sperm interaction
Jha, R. K., Jha, R. K., Jha, P. K., et al. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4818 · Cited by 28 · see citing works
Contrast‐enhanced MR imaging of the liver
Runge, V. M., Rijcken, T. H. P., Davidoff, A., et al. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040311 · Cited by 27 · see citing works
Contrast agents for MR imaging of the liver: a clinical overview
Mahfouz, A. E., Hamm, B., & Taupitz, M. (1997) · European Radiology · doi:10.1007/s003300050193 · Cited by 25 · see citing works
Takeshita, K., Nagashima, I., Frui, S., et al. (2002) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200205000-00024 · Cited by 19 · see citing works
Superparamegnetic iron oxides for MRI
Weissleder, R., & Reimer, P. (1993) · European Radiology · doi:10.1007/bf00425895 · Cited by 18 · see citing works
Scott, J. G., Ward, J., Guthrie, J. A., et al. (2000) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(00)00116-8 · Cited by 18 · see citing works
Status of contrast media research in MRI, ultrasound and X-ray
Fritzsch, T., Kŕause, W., & Weinmann, H. (1992) · European Radiology · doi:10.1007/bf00714174 · Cited by 17 · see citing works
Superparamagnetic iron oxide imaging of focal liver disease
Taylor, P. M., Hawnaur, J. M., & Hutchinson, C. E. (1995) · Clinical Radiology · doi:10.1016/s0009-9260(05)83472-5 · Cited by 16 · see citing works
Frate, C. D., Zuiani, C., Londero, V., et al. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.180.5.1801339 · Cited by 16 · see citing works
MR – eyes for cancer: looking within an impenetrable disease
Penet, M., Artemov, D., Farahani, K., & Bhujwalla, Z. M. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2980 · Cited by 14 · see citing works
“5 T of superparamagnetic ferrite particles to detect metastasis did not show significantly more metastases in contrast-enhanced images compared with regular T2-weighted images (72).”
BackgroundKothapalli, S. V. V. N., Oddo, L., Paradossi, G., et al. (2014) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2014.05.018 · Cited by 14 · see citing works
A multicenter measurement of magnetization transfer ratio in normal white matter
Berry, I., Barker, G. J., Barkhof, F., Campi, A., Dousset, V., Franconi, J., Gass, A., Schreiber, W., Miller, D. H., & Tofts, P. S. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199903)9:3 · Cited by 120 · see citing works
Self-citationMagnetic Resonance Imaging of Diseases of the Liver and Biliary System
Kanzer, G. K., & Weinreb, J. C. (1991) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)02477-0 · Cited by 14 · see citing works
Deckers, F., Corthouts, B., Nackaerts, Y., et al. (1997) · European Radiology · doi:10.1007/s003300050222 · Cited by 13 · see citing works
“In recent years the issue of image quality related to field strength in general, and the effect of field strength on SPIO in particular, have been the subject of discussion [1, 4, 7].”
BackgroundPotential contrast agents for magnetic resonance imaging
Coroiu, I., Darabont, A., & Demco, D. E. (1998) · Applied Magnetic Resonance · doi:10.1007/bf03162035 · Cited by 12 · see citing works
Kreft, B., Block, W., Dombrowski, F., et al. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.3.9490949 · Cited by 12 · see citing works
Ishida, T., Murakami, T., Kato, N., Takahashi, M., Miyazawa, T., Tsuda, K., Tomoda, K., Narumi, Y., & Nakamura, H. (1997) · Investigative Radiology · doi:10.1097/00004424-199705000-00005 · Cited by 12 · see citing works
Nanomaterials for cardiac tissue engineering
Sapir, Y., Polyak, B., & Cohen, S. (2013) · Elsevier eBooks · doi:10.1533/9780857097231.2.244 · Cited by 12 · see citing works
MR imaging of hepatocellular carcinoma at 1.5 Tesla
Rosenthal, R. E., & Davis, P. L. (1992) · Abdominal Imaging · doi:10.1007/bf01888508 · Cited by 9 · see citing works
“New exper imental l iver-contrast agents show promise in increasing the l iver - les ion tissue contrast and this should increase detectabil i ty of tumors [6-11].”
BackgroundIron Oxide Enhanced MR Imaging of the Liver and Spleen: Review of the First Five Years.
Ferrucci, J. T. (1991) · The Keio Journal of Medicine · doi:10.2302/kjm.40.206 · Cited by 9 · see citing works
Groman, E. V., Yang, M., Reinhardt, C. P., Weinberg, J. S., & Vaccaro, D. E. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-008-9082-5 · Cited by 8 · see citing works
“Monocrystalline iron oxide nanoparticle (MION) and MION-like superparamagnetic iron oxide nanoparticles have been extraordinarily useful in a broad range of applications including: immunoassays [1, 2], detection and separation of cells, viruses, hormones, oligonucleotides, DNA and proteins [3–8], cell tagging, trackin…”
BackgroundPOLYOXYDES DE POLYPHOSPHINES BICYCLIQUES ALKYLÉS SUR LE PHOSPHORE
Toulhoat, C., Vidal, M., & Vincens, M. (1993) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426509308032428 · Cited by 8 · see citing works
Insights of an abdominal imager: What do we need for MRI enhancement?
Kressel, H. Y. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910220232 · Cited by 8 · see citing works
Kim, S. H., Choi, D., Lim, H. K., et al. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.03.016 · Cited by 7 · see citing works
Mahfouz, A., & Hamm, B. (1997) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/s1064-9689(21)00194-x · Cited by 7 · see citing works
Role of Metals, Metal Oxides, and Metal Sulfides in the Diagnosis and Treatment of Cancer
Pachaiappan, R., & Manavalan, K. (2021) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-56413-1_6 · Cited by 5 · see citing works
SUPERPARAMAGNETIC IRON OXIDE‐ENHANCED MAGNETIC RESONANCE IMAGING OF THE LIVER IN BEAGLE DOGS
Chang, D., Kim, B., Yun, Y., et al. (2002) · Veterinary Radiology & Ultrasound · doi:10.1111/j.1740-8261.2002.tb00440.x · Cited by 5 · see citing works
Role of magnetic resonance imaging in the staging of gastrointestinal neoplasms
Ferraris, R., del Piano, A., & Galli, J. J. (2001) · Seminars in Surgical Oncology · doi:10.1002/ssu.1025 · Cited by 5 · see citing works
Fröhlich, J. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20033 · Cited by 5 · see citing works
Magnetic Nanomaterials as MRI Contrast Agents
Gun’ko, Y. K., & Brougham, D. F. (2009) · Nanotechnologies for the Life Sciences · doi:10.1002/9783527610419.ntls0166 · Cited by 4 · see citing works
Duerk, J. L., & Hurst, G. C. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040329 · Cited by 4 · see citing works
Tsai, C. S., Chen, H. Y., & Chang, K. P. (2011) · Key engineering materials · doi:10.4028/www.scientific.net/kem.474-476.1776 · Cited by 3 · see citing works
Internationalization of gold and nickel nanowires by living cells
Yu, H., Tsai, Y.-T., Wang, H., et al. (2008) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.777138 · Cited by 3 · see citing works
Evaluation of the changes in signals from the spleen using ferucarbotran
Gomi, T., Nagamoto, M., Tsunoo, M., et al. (2007) · Radiation Medicine · doi:10.1007/s11604-006-0108-0 · Cited by 3 · see citing works
Entry of large nanoparticles into cells aided by nanoscale mechanical stimulation
Vaidyanathan, R., Curtis, A. S. G., & Mullin, M. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0516-7 · Cited by 3 · see citing works
Core–Shell Magnetic Nanomaterials in Medical Diagnosis and Therapy
Melancon, M. P., & Li, C. (2009) · Nanotechnologies for the Life Sciences · doi:10.1002/9783527610419.ntls0169 · Cited by 3 · see citing works
- Authors
- Marchal, G., Van Hecke, P., Demaerel, P., Decrop, E., Kennis, C., Baert, A., & van der Schueren, E.
- Affiliations
- KU Leuven (BE)
- Department of Radiology, University Hospitals, K.U. Leuven, Belgium.
- ORCID
- Demaerel, P
- Venue
- American Journal of Roentgenology
- Publisher
- American Roentgen Ray Society
- Published
- 1989-04-01
- Volume
- 152
- Issue
- 4
- Pages
- 771-775
- ISSN
- 0002-9580 (ISSN-L)
- 0361-803X
- 1546-3141
- OpenAlex
- W1963756164
- Cited by
- 122
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2019: 3 · 2017: 1 · 2014: 2 · 2013: 4
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Roentgenology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Keywords
- liver metastasis, superparamagnetic iron oxide nanoparticles, MRI contrast agents, ferrite particles, contrast-enhanced MRI, T2-weighted imaging, lesion detection, 1.5T MRI
- MeSH terms
- Aged, Female, Ferric Compounds, Humans, Injections, Intravenous, Liver Neoplasms, Magnetic Resonance Imaging, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review